![](https://ml.globenewswire.com/media/e94148e0-0631-403b-9597-c742d43dca13/small/rakovina-logo-mar2021-png.png)
Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement
VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, announces that, …